Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: J Stone who wrote (24452)	8/13/1998 2:04:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< Don't forget SRGN has some production facilities which have a certain value to LGND which really has none. >> Good point. An earlier note, about Ligand being able to take advantage of Seragan's accumlated losses, for tax purposes, was also something to ponder. It would be helpful, if someone with a tax background would provide some thoughts about that issue. If Ligand could take advantage of most of the $210+ million in accumulated losses, for tax offsets, that could possibly be more valuable than short term ONTAK sales. Good luck, Bob